Novo Nordisk India

Novo Nordisk India launches world’s first and only GLP-1 RA, Oral Semaglutide- a gamechanger in diabetes

Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), indicated for the management of type 2 diabetes has been developed in an…

3 years ago

National Insulin Summit draws over 300 leading Indian doctors to discuss innovations in insulin therapy

Hyderabad, November 20, 2018: The National Insulin Summit, one of India’s most prestigious medical symposiums, conducted by Diabetes Research Society (DIABAID) and…

6 years ago